Albany Molecular Research, Inc. Announces Second Quarter Results

ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ: AMRI) today reported strong earnings growth driven by increased milestone and royalty revenue, revenue growth in both the Discovery Services and Development/Small Scale contract services business components, and continued improvement in gross margin in Large Scale Manufacturing.
MORE ON THIS TOPIC